These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 20428812)

  • 1. Potential of molecular targeted therapy of HER-2 and Cox-2 for invasive transitional cell carcinoma of the urinary bladder.
    Naruse K; Yamada Y; Nakamura K; Aoki S; Taki T; Zennami K; Katsuda R; Watanabe M; Nishikawa G; Itoh Y; Mitsui K; Hibi H; Honda N
    Oncol Rep; 2010 Jun; 23(6):1577-83. PubMed ID: 20428812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential for molecular-targeted therapy targeting human epidermal growth factor receptor-2 for invasive bladder cancer.
    Yamada Y; Naruse K; Nakamura K; Aoki S; Taki T; Tobiume M; Zennami K; Katsuda R; Inoue Y; Noguchi H; Honda N
    Oncol Rep; 2007 Jul; 18(1):3-7. PubMed ID: 17549338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential for HER-2/neu molecular targeted therapy for invasive bladder carcinoma: comparative study of immunohistochemistry and fluorescent in situ hybridization.
    Matsubara H; Yamada Y; Naruse K; Nakamura K; Aoki S; Taki T; Tobiume M; Zennami K; Katsuda R; Honda N
    Oncol Rep; 2008 Jan; 19(1):57-63. PubMed ID: 18097576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2 expression in urinary bladder transitional cell carcinoma and its association with clinicopathological characteristics.
    Tabriz HM; Olfati G; Ahmadi SA; Yusefnia S
    Asian Pac J Cancer Prev; 2013; 14(8):4539-43. PubMed ID: 24083698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
    J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-2 expression increases with the stage and grade in transitional cell carcinoma of the urinary bladder.
    Wadhwa P; Goswami AK; Joshi K; Sharma SK
    Int Urol Nephrol; 2005; 37(1):47-53. PubMed ID: 16132759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential for molecular targeted therapy of HER-2/neu for invasive bladder cancer: examination of gene amplification by fluorescence in situ hybridization.
    Yamada Y; Naruse K; Nakamura K; Aoki S; Taki T; Tobiume M; Zennami K; Katsuda R; Hirano M; Hayashida K; Mizumukai E; Nanaura H; Honda N
    Oncol Rep; 2007 Nov; 18(5):1183-7. PubMed ID: 17914570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of cyclooxygenase-2 expression with molecular markers, pathological features and clinical outcome of transitional cell carcinoma of the bladder.
    Shariat SF; Matsumoto K; Kim J; Ayala GE; Zhou JH; Jian W; Benedict WF; Lerner S
    J Urol; 2003 Sep; 170(3):985-9. PubMed ID: 12913755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic variables in patients who have undergone radical cystectomy for transitional cell carcinoma of the bladder.
    Hara S; Miyake H; Fujisawa M; Okada H; Arakawa S; Kamidono S; Hara I
    Jpn J Clin Oncol; 2001 Aug; 31(8):399-402. PubMed ID: 11574634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification.
    Pagano F; Bassi P; Galetti TP; Meneghini A; Milani C; Artibani W; Garbeglio A
    J Urol; 1991 Jan; 145(1):45-50. PubMed ID: 1984097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications.
    Wankowicz SAM; Werner L; Orsola A; Novak J; Bowden M; Choueiri TK; de Torres I; Morote J; Freeman GJ; Signoretti S; Bellmunt J
    J Urol; 2017 Oct; 198(4):817-823. PubMed ID: 28487100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation.
    May M; Helke C; Nitzke T; Vogler H; Hoschke B
    Urol Int; 2004; 72(2):103-11. PubMed ID: 14963349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of HER2 status in bladder transitional cell carcinoma revealed by both IHC and BDISH techniques.
    Nedjadi T; Al-Maghrabi J; Assidi M; Dallol A; Al-Kattabi H; Chaudhary A; Al-Sayyad A; Al-Ammari A; Abuzenadah A; Buhmeida A; Al-Qahtani M
    BMC Cancer; 2016 Aug; 16():653. PubMed ID: 27539085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of lymph node metastasis based on p53 and nm23-H1 expression in muscle invasive grade III transitional cell carcinoma of bladder.
    Park DS; Lee YT; Lee JM
    Adv Exp Med Biol; 2003; 539(Pt A):67-85. PubMed ID: 15088897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-2 expression in invasive transitional cell carcinoma of the urinary bladder.
    Yamada Y; Nakamura K; Inoue Y; Naruse K; Aoki S; Taki T; Tobiume M; Zennami K; Katsuda R; Hara K; Kyoku I; Mitsutake N; Arakawa M; Saito H; Hasegawa T; Noguchi H; Honda N
    Mol Med Rep; 2008; 1(6):791-5. PubMed ID: 21479487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of cathepsin D levels in invasive bladder cancer and its stroma. Correlation with tumor stage, cytological grade, lymph node metastasis and survival].
    Carrascosa Lloret C; Cremades Mira A; Sánchez Sanchis M; Rodrigo Guanter V; Beltrán Armada JR; Sala Aznar A; Vacacela Córdova R; Coronel Sánchez B; Clar Blanch F; Tarin Planes M; Sanjuán de Laorden C
    Actas Urol Esp; 2002 May; 26(5):335-8. PubMed ID: 12174741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor-C (VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder.
    Suzuki K; Morita T; Tokue A
    Int J Urol; 2005 Feb; 12(2):152-8. PubMed ID: 15733109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immunohistochemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas.
    Dickinson AJ; Fox SB; Newcomb PV; Persad RA; Sibley GN; Harris AL
    J Urol; 1995 Jul; 154(1):237-41. PubMed ID: 7776437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of hedgehog pathway components is associated with bladder cancer progression and clinical outcome.
    He HC; Chen JH; Chen XB; Qin GQ; Cai C; Liang YX; Han ZD; Dai QS; Chen YR; Zeng GH; Zhu JG; Jiang FN; Zhong WD
    Pathol Oncol Res; 2012 Apr; 18(2):349-55. PubMed ID: 21861243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.